Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming Stars #28: Stem Cell-Based Approaches to Build Blood Vessels and Liver Tissue-An Interview with Dr. Lay Teng Ang.

Cellular reprogramming·2026
Same author

Protocol for identifying cellular reprogramming minimal networks using combinatorial transcription factor screening.

STAR protocols·2026
Same author

Turning tumors against themselves.

Science (New York, N.Y.)·2026
Same author

Reprogramming Stars #27: Drawing Inspiration from Reprogramming to Guide Stem Cell Differentiation: An Interview with Dr. Kyle Loh.

Cellular reprogramming·2026
Same author

A combinatorial transcription factor screening platform for immune cell reprogramming.

Cell systems·2026
Same author

Reprogramming Stars #26: Understanding the Reprogramming Privilege-An Interview with Dr. Shangqin Guo.

Cellular reprogramming·2025
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.4K

Understanding and Modulating Immunity With Cell Reprogramming.

Cristiana F Pires1,2,3, Fábio F Rosa1,2,3, Ilia Kurochkin4

  • 1Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Lund Stem Cell Center, Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.

Frontiers in Immunology
|January 11, 2020
PubMed
Summary
This summary is machine-generated.

Scientists reprogrammed fibroblasts into dendritic cells (DCs) using specific transcription factors. This breakthrough in cell reprogramming offers new avenues for regenerative medicine and cancer immunotherapy.

Keywords:
antigen presentationcancer immunotherapycell fate reprogrammingdendritic cellhematopoiesisregenerative medicinetranscription factortransdifferentiation

More Related Videos

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.7K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K

Related Experiment Videos

Last Updated: Dec 31, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.4K
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.7K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Immunology
  • Regenerative Medicine

Background:

  • Cell reprogramming, classically studied in developmental and stem cell biology, holds promise for regenerative medicine by generating specific cell types for therapy.
  • Experimental reversal or modification of cell fate can be achieved through enforced expression of lineage-specific transcription factors, leading to pluripotency or new somatic cell identities.

Purpose of the Study:

  • To explore the potential of cell reprogramming for generating functional immune cells, specifically dendritic cells (DCs), for therapeutic applications.
  • To identify the minimal gene regulatory networks sufficient for imposing a DC fate onto unrelated cell types.
  • To bridge cell fate engineering with immunology for novel insights into immune system function and disease.

Main Methods:

  • Enforced expression of transcription factors PU.1, IRF8, and BATF3 to reprogram fibroblasts into induced dendritic cells (iDCs).
  • Utilizing Clec9a, a C-type lectin receptor, for its restricted expression in conventional DC type 1, to facilitate DC fate induction.
  • Reviewing existing literature on cell reprogramming, hematopoiesis, and immunology.

Main Results:

  • Demonstrated that PU.1, IRF8, and BATF3 are sufficient and necessary to induce DC identity in non-DC cell types.
  • Identified minimal gene regulatory networks governing hematopoietic development and lineage heterogeneity.
  • Showcased the potential for generating patient-tailored reprogrammed immune cells for cancer immunotherapy.

Conclusions:

  • Direct cell reprogramming of fibroblasts into functional dendritic cells represents a paradigm shift in understanding and manipulating the immune system.
  • The identified transcription factors and regulatory networks provide crucial insights into the molecular mechanisms of cell fate determination.
  • Merging cell fate engineering with immunology opens new therapeutic opportunities, particularly in cancer immunotherapy and understanding immune responses in health and disease.